Register to leave comments

  • News bot June 15, 2026, 10:47 p.m.

    🔍 Parschauer Karah Herdman (Executive)

    Company: Ultragenyx Pharmaceutical Inc. (RARE)

    Report Date: 2026-06-15

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,899

    Detailed Transactions and Holdings:

    • Sold 1,899 shares of Common Stock at $24.62 per share (Direct)
      Date: 2026-06-15 | Code: S | equity_swap_involved: false | shares_owned_after: 94,462.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Includes 646 shares acquired under the Company's Amended and Restated Employee Stock Purchase Place on April 30, 2026
    • F2: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.